Anika Therapeutics (ANIK) Earnings Date, Estimates & Call Transcripts → Biden replacement revealed? (From Paradigm Press) (Ad) Free ANIK Stock Alerts $25.90 +0.11 (+0.43%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 8After Market ClosesConfirmedActual EPS (Mar. 13) $0.05 Beat By $0.20 Consensus EPS (Mar. 13) -$0.15 Get Anika Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ANIK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueANIK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANIK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Anika Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.28)($0.28)($0.28) Q2 20241($0.20)($0.20)($0.20) Q3 20241($0.17)($0.17)($0.17) Q4 20241($0.07)($0.07)($0.07) FY 20244($0.72)($0.72) ($0.72)ANIK Earnings Date and InformationAnika Therapeutics last issued its quarterly earnings results on March 13th, 2024. The biotechnology company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.15) by $0.20. The business earned $42.97 million during the quarter, compared to the consensus estimate of $41.51 million. Anika Therapeutics has generated ($5.65) earnings per share over the last year (($5.65) diluted earnings per share). Earnings for Anika Therapeutics are expected to grow by 20.54% in the coming year, from $1.12 to $1.35 per share. Anika Therapeutics has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Anika Therapeutics will be holding an earnings conference call on Wednesday, May 8th at 5:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Anika Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Confirmed)------- 3/13/2024Q4 2023($0.15)$0.05+$0.20$4.40$41.51 million$42.97 million8/8/2023Q2 2023($0.27)($0.06)+$0.21$0.07$40.61 million$44.30 million5/9/2023Q1 2023($0.29)($0.36)($0.07)($0.01)$37.16 million$37.92 million3/6/2023Q4 2022($0.15)($0.21)($0.06)($0.08)$38.32 million$39.62 million11/8/2022Q3 2022($0.18)($0.05)+$0.13$0.19$36.56 million$40.26 million8/3/2022Q2 2022($0.19)($0.12)+$0.07($0.04)$36.40 million$39.66 million Get the Latest News and Ratings for ANIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anika Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/5/2022Q1 2022($0.24)($0.11)+$0.13($0.02)$33.90 million$36.69 million 3/8/2022Q4 2021-($0.23)($0.23)($0.06)$32.85 million$35.82 million 11/4/2021Q3 2021($0.21)$0.05+$0.26$0.06$36.45 million$39.54 million 8/4/2021Q2 2021($0.15)$0.45+$0.60($0.27)$34.51 million$38.15 million 5/5/2021Q1 2021$0.01$0.20+$0.19($0.08)$32.39 million$34.29 million Anika Therapeutics Earnings - Frequently Asked Questions When is Anika Therapeutics's earnings date? Anika Therapeutics has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on ANIK's earnings history. Did Anika Therapeutics beat their earnings estimates last quarter? In the previous quarter, Anika Therapeutics (NASDAQ:ANIK) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.20. Learn more on analysts' earnings estimate vs. ANIK's actual earnings. How much revenue does Anika Therapeutics generate each year? Anika Therapeutics (NASDAQ:ANIK) has a recorded annual revenue of $166.66 million. How much profit does Anika Therapeutics generate each year? Anika Therapeutics (NASDAQ:ANIK) has a recorded net income of -$82.67 million. ANIK has generated -$5.65 earnings per share over the last four quarters. What is Anika Therapeutics's price-to-earnings ratio? Anika Therapeutics (NASDAQ:ANIK) has a forward price-to-earnings ratio of 23.13. The price/earnings-to-growth ratio is 2.32. What is Anika Therapeutics's EPS forecast for next year? Anika Therapeutics's earnings are expected to grow from $1.12 per share to $1.35 per share in the next year, which is a 20.54% increase. More Earnings Resources from MarketBeat Related Companies: OSUR Earnings CERS Earnings UTMD Earnings ATRI Earnings SRDX Earnings NPCE Earnings BVS Earnings CVRX Earnings TCMD Earnings PLSE Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:ANIK) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
